Market Overview

UPDATE: ISI Group Upgrades Cardinal Health to Overweight; Pricing Fears Overdone

Share:
Related CAH
Jefferies: Weakening Generic Drug Prices Putting Pressure On 3 Healthcare Stocks
7 Stocks To Watch For May 1, 2017

ISI Group raised its rating on Cardinal Health (NYSE: CAH) from Market Weight to Overweight and increased its price target from $45 to $46.

ISI Group noted, "We believe that fears over pricing on the upcoming WAG and CVS contracts are overwrought by investors and overpriced in CAH shares. At ~6x EV/EBITDA, CAH offers investors ~9% FCF yield (ex one-time items) and high-single-digit EPS growth in the medium-term with downside already baked in to expectations (~3-5% hit to EPS from re-pricing pressures with cost leverage to cushion)."

Cardinal Health closed at $40.85 on Monday.

Latest Ratings for CAH

DateFirmActionFromTo
May 2017JefferiesInitiates Coverage OnHold
Apr 2017Tigress FinancialInitiates Coverage OnNeutral
Apr 2017William BlairDowngradesOutperformMarket Perform

View More Analyst Ratings for CAH
View the Latest Analyst Ratings

Posted-In: ISI GroupAnalyst Color Upgrades Intraday Update Analyst Ratings

 

Related Articles (CAH)

View Comments and Join the Discussion!